专利检索 ap:("MITSUBISHI TANABE PHARMA CORPORATION") AND inv:"Vincent Blot" 第 1 页

1.

发明授权
CMET monoclonal binding agents, drug conjugates thereof and uses thereof 有权

公开(公告)号：US11299547B2

公开(公告)日：2022-04-12

申请号：US16334326

申请日：2017-09-28

申请人： MITSUBISHI TANABE PHARMA CORPORATION

发明人： Julia Coronella , Vincent Blot , Marco Gymnopoulos , Anjuli Timmer , Ryo Fujita , Roland Newman

IPC分类号： C07K16/28 , A61P35/00

摘要： Presented herein, in certain embodiments, are compositions comprising monoclonal binding agents that specifically bind to the extracellular domain of cMET and uses thereof.

2.

发明授权
Drug conjugates of cMET monoclonal binding agents, and uses thereof 有权

公开(公告)号：US12060427B2

公开(公告)日：2024-08-13

申请号：US17042013

申请日：2019-03-27

申请人： MITSUBISHI TANABE PHARMA CORPORATION

发明人： Julia Coronella , Marco Gymnopoulos , Vincent Blot , Ryo Fujita , Roland Newman

IPC分类号： C07K16/28 , A61K31/5517 , A61K39/00 , A61K47/64 , A61P35/00

CPC分类号： C07K16/2863 , A61K31/5517 , A61K47/6415 , A61P35/00 , A61K2039/505

摘要： Presented herein are novel monoclonal cMET binding agents that are conjugated to pyrrolobenzodiazepine toxins, composition thereof and uses thereof for the treatment of cancer.